News · 26 weeks130%
2026-03-012026-08-23
Mix1390d
- Market11(85%)
- Other1(8%)
- Dividends1(8%)
Latest news
25 items- NEWSDataMeds AI Reports Second Quarter 2026 Financials and Provides Business UpdateRevenues grew 14% reaching $1.779M in Q2/26, beating management projectionsCorporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to 'MEDS' on NASDAQ Capital Markets$6.5 million new funding in June 2026 provided capital to support corporate turnaroundPending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience to pati
- NEWSDataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today announced that its board of directors (the "Board") fixed September 9, 2026 (the "Payment Date") as the date on which the previously announced distribution (the "Distribution") of Dream Bowl Meme Coin I tokens (the "Dream Bowl Tokens") will be
- NEWSDataMeds AI Provides Update on Corexa Health's Pharmacy DivisionGLP-1 agonist drugs now availableIntegration of online store CorexaRx.com into Health Lives Here app now completeMedical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now availableRevenue stabilized above $600,000 for July 2026 amid rebranding as pharmacy prepares to expand through the launch of Health Lives Here app with NFL Alumni Health TAMPA, FL / ACCESS Newswire / August 12, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrate
- NEWSDataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health DivisionTAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that it has completed the name changes of its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy, LLC ("Corexa Pharmacy") and Corexa Tech & Hub, LLC ("Corexa Hub"), respectively. Corexa Pharmacy and Corexa Hub are themselves subsidiaries of the Company's newly renamed pharmacy-focused division Corexa Hea
- NEWSDataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record DateTAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today reiterated the August 7, 2026 record date for the 50:1 token to stock ratio for the Dream Bowl Meme Coin token (to DataMEDS common shares.The official platform for Dream Bowl Meme Coin tokens is https://www.biconomy.com/exchange/DREAM1_USDT. Dream Bowl Meme Coin token is not authorized to trade on CoinBase https://www.coi
- NEWSDataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient engagement tools TAMPA, FL / ACCESS Newswire / August 5, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," the "Company" or "DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that Interim Co-CEO Gerald Commissiong will be featured with a marquee NFL Hall of Famer with
- NEWSDataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that its wholly-owned online pharmacy, Corexa Pharmacy (www.CorexaRx.com/store), has begun direct-to-consumer (DTC) distribution of Tollovid®, a 3CL protease inhibitor dietary supplement, and Galactovid™, a medical food for the dietary
- NEWSDataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization LicenseData monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX PlatformHealthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data TAMPA, FL / ACCESS Newswire / July 29, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data and Datavault AI Inc. ("Datavault AI" or the
- PRDatavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AIDatavault AI extends data monetization and real-world asset tokenization technologies into the DataMeds AI’s EinsteinRX Platform Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (‘RWA’) tokenization technologies, today announced that it has amended its definitive agreement with DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS") to expand its PharmacyChain blockchain-related technology licensing relationship beyon
- NEWSDataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to StockholdersTAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS, " or the "Company")), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey, today announced an updated record date for the distribution of the Dream Bowl 2026 Meme Coin (https://www.biconomy.com/exchange/DREAM1_USDT) to DataMEDS stockholders. On December 3, 2025, DataMEDS announced that it would distribute one (1) Dream Bowl 2026 Meme Coin for every one (1) share of DataMEDS Health common stock held as of
- NEWSDataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital MarketsTrading under new symbol (NASDAQ:MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ:WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS, " or the "Company")), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data, today announced that it has officially completed its stock trading symbol change to 'MEDS'. The Company began trading under the new stock symbol 'MEDS' on the NASDAQ Capital Market stock ex
- PRWELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare DataTAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellgistics Health, Inc., (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it has officially completed its name change to DataMEDS AI, Inc. ("DataMEDS" or "the Company"). Simultaneous with this announcement, the Company announced that it will begin trading under the stock symbol 'MEDS' on the NASDAQ Capital Market stock exchange on Wednesday, July 22, 2026.
- NEWSSCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYCCOMMACK, NY / ACCESS Newswire / June 4, 2026 / SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty products that address unmet market needs, today announced that members of its executive management team will participate in The Small Cap Showcase & WTR Insights, taking place on June 9, 2026, in New York City.Narasimhan Mani, President, co-CEO and Interim CFO of Scienture, will deliver a corporate presentation at 1:30 p.m. ET. A live webcast of the Company's presentation will
- NEWSWellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder ValueTAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced key additions to its executive leadership team and Board of Directors. These strategic appointments reflect the Company's commitment to executing on its growth strategy, enhancing operational scale, and delivering long-term shareholder value.Key Leadership AppointmentsWellgistics has appointed a diverse and deeply experienced group of executives to drive execution across the Company's operations:Tony Madsen, Chief Operating Officer (COO) - A seasoned executive with over a decade of regulatory compliance, cy
- PROragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEOSARASOTA, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today provided an update on its strategic progress since its last capital raise in September 2024. The Company also announced the appointment of Janet Huffman as its new interim Chief Executive Officer. Strategic Progress Since Capital Raise Following the Company's $4 million capital raise in September 2024, the Company has made significant advancements, including: Formulation and Device Enhancements: The Company has improved the formulation and intranasal delivery device for ONP-002 and in connection therewith
- SECTRxADE HEALTH Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Scienture Holdings, Inc. (0001382574) (Filer)
- PRTRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to "SCNX"TRxADE Health, Inc. today announced that it changed its name and ticker symbol to "Scienture Holdings, Inc." and "SCNX", respectively, and that the business will continue as a Nasdaq-listed company. TAMPA, FL, Sept. 24, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (the "Company") (NASDAQ:MEDS) and Scienture, LLC ("Scienture"), a wholly owned subsidiary of the Company, today announced that the Company has changed its name to "Scienture Holdings, Inc." Effective as of September 23, 2024, the Company's stock is now trading on the Nasdaq Stock Market LLC under the new ticker symbol "SCNX". Scienture Holdings, Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions
- PRTRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. ("TRxADE") (NASDAQ:MEDS) and Scienture, LLC ("Scienture"), a wholly owned subsidiary of TRxADE, today announced that it is changing its name to Scienture Holdings, Inc. ("Scienture Holdings"), effective Monday, September 23, 2024. Scienture Holdings stock will begin trading under the new ticker symbol NASDAQ:SCNX on September 23, 2024. About TRxADE TRxADE HEALTH, INC. historically focused on health services IT assets and operations aimed at digitalizing the retail pharmacy experience. Our current primary operations are conducted through our wholly-owned subsidiary, Integra Pharma Solutions, LLC ("IPS"), whi
- SECSEC Form DEF 14C filed by TRxADE HEALTH Inc.DEF 14C - TRxADE HEALTH, INC (0001382574) (Filer)
- SECSEC Form PRE 14C filed by TRxADE HEALTH Inc.PRE 14C - TRxADE HEALTH, INC (0001382574) (Filer)
- SECSEC Form 10-Q filed by TRxADE HEALTH Inc.10-Q - TRxADE HEALTH, INC (0001382574) (Filer)
- INSIDERNew insider Shankar Hariharan claimed ownership of 97,087 shares (SEC Form 3)3 - TRxADE HEALTH, INC (0001382574) (Issuer)
- INSIDERNew insider Narasimhan Mani claimed ownership of 57,977 shares (SEC Form 3)3 - TRxADE HEALTH, INC (0001382574) (Issuer)
- PRTRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership TeamTAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. ("TRxADE") (NASDAQ:MEDS) and Scienture, LLC ("Scienture"), a wholly owned subsidiary of TRxADE, today announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture's President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., MBA has been promoted to Executive VP and COO of Scienture. Dr. Narasimhan Mani is an experienced healthcare professional and a proven leader with over 25 years of experience in both the scientific and business areas of the pharmaceutical industry. He currently is a part of the Executives-in-Residence program at New Rhein Hea
- SECTRxADE HEALTH Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - TRxADE HEALTH, INC (0001382574) (Filer)
MEDS FAQ
6 questionsWhat does TRxADE HEALTH Inc. do?
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes...Where does MEDS stock trade?
TRxADE HEALTH Inc. (MEDS) is listed on NASDAQ.What sector and industry is MEDS in?
TRxADE HEALTH Inc. operates in the Health Care sector, Other Pharmaceuticals industry.What are analysts saying about MEDS?
TRxADE HEALTH Inc. has had 1 recent analyst action on file. The most recent action was from EF Hutton: Buy with a $450.00 price target on 2021-12-09. Recent price targets cluster around $450.00.What companies are similar to MEDS?
Notable peers in the same industry include MCK (McKesson Corporation), COR (Cencora Inc.), CAH (Cardinal Health Inc.), ABC (AmerisourceBergen Corporation), CVET (Covetrus Inc.). Compare MEDS side-by-side with any of them on Quantisnow.How can I track MEDS on Quantisnow?
Quantisnow aggregates TRxADE HEALTH Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MEDS to receive live email and push alerts on every new disclosure.